Struggling to select M&A or RX for full-time

In need of some advice. This past summer I had the opportunity to work at a boutique with a generalist process with well-regarded M&A and RX teams. From what I have read across WSO, the RX team is ever so slightly more well-known/regarded than the M&A team. I enjoyed the work in both groups and connected with the people equally. Struggling to make a decision about which team I would like to pursue heavily come group placement full-time. I want the best learning experience and think both groups are equally hour intensive. 

For context, I am planning on participating in on-cycle and in the process of figuring out whether I am more interested in traditional buyout vs special situations/distress. Not sure how important this is for the above decision seeing as on cycle will take place before group placement is determined. 

Might be putting too much weight on this decision - appreciate the help/advice. 

 

If you’re interested in buyout then do M&A. You’re going to learn a different skillset in Rx albeit very technical. You’re going to look at businesses in a different way than an M&A banker.

 

not OP, but would you be looking at businesses through the lens of assets as an RX guy vs cash flow as an M&A guy, or is there a bigger difference im missing?

 

Which EBs would you consider "top"? Is it worthwhile to consider market conditions during analyst years?

 
Most Helpful

PJT, EVR, MOE, HL, LAZ, GUGG, CVP, PWP are all good groups for rx

if you're asking about MF buyout exits then PJT and EVR are materially above the rest

if you're asking about EBs where the Rx group > M&A group for buyout exits:

PJT Rx > M&A

EVR Rx >= M&A

MOE Rx = M&A

LAZ Rx = M&A

HL Rx >>>>>>> M&A

GUGG Rx = M&A

CVP Rx < M&A

PWP Rx >= HC, > rest of M&A

for op i don't really know which of these are generalist or not for analyst programs but certain most of them aren't

 

From all the info you have given regarding group placement timelines and bank, this sounds like you're going to Lazard NYC. I am not at Lazard, so some specifics may be incorrect, but this is my take on it. RX is the most difficult group to place into at Lazard NYC. It is also the best group in terms of exits, for both buyouts and obviously for distressed. That office however is not a lifestyle group, so just know what you are getting into. If you do focus heavily on RX, make sure you plan for not placing into it. Have heard anecdotally that almost half the class marks RX as their top choice. As for whether to work on RX or M&A, that is a decision you have to make. Personally, I love RX workstreams much more than M&A workstreams and I believe it is a better learning experience.

 

Think about how you want to spend your day on a human level. Do you want to deal with struggling companies, stressed clients, and more of a "damage control" role? Or do you want to deal with maximizing value, strategic rationale, synergies, etc? This should not only aid your decision in M&A vs. RX, but also buy-outs vs. distressed investing. This is not an attempt to favor one over the other, just a generalization of what each focuses on and their goals. 

 

Iste ab hic magni omnis in. Rerum hic voluptatem mollitia ipsa exercitationem nesciunt velit. Rerum totam ad velit velit voluptates eaque.

Quae aspernatur impedit provident quia. Modi repellendus sapiente aut id perferendis sit. Labore tenetur non unde sit enim nesciunt soluta. Et aut possimus omnis ut rerum eaque. Quae maxime ea accusantium nostrum nihil quam.

Sunt ut quas omnis cumque enim accusamus. Quasi earum et nam reiciendis consequuntur. Asperiores adipisci cum harum deleniti commodi.

Career Advancement Opportunities

May 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 04 97.1%

Overall Employee Satisfaction

May 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

May 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

May 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (88) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (67) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Secyh62's picture
Secyh62
99.0
4
Betsy Massar's picture
Betsy Massar
99.0
5
GameTheory's picture
GameTheory
98.9
6
dosk17's picture
dosk17
98.9
7
kanon's picture
kanon
98.9
8
CompBanker's picture
CompBanker
98.9
9
numi's picture
numi
98.8
10
Linda Abraham's picture
Linda Abraham
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”